Cognition Therapeutics

Price & Volume

Stats

52W Range	$0.22-$3.83
Market Cap	$80.8M
Shares Short	6M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$0.32

News

Yahoo Finance • 19 days ago

Pre-Market Earnings Report for March 26, 2026 : CMC, DOO, SCVL, DBI, LOVE, LUCD, ABOS, CGTX, RMTI

Yahoo Finance • 24 days ago

3 things to look forward to on Monday

Yahoo Finance • 4 months ago

Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Yahoo Finance • 4 months ago

Cognition Therapeutics Presents Phase 3 Plan for Zervimesine (CT1812) in Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference

About

CEO	Ms. Lisa Ricciardi
Address	2500 Westchester Ave., Purchase, NY, United States, 10577
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	14